AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7265042 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonography during arterial time in the plane of the arteries
Number of subjects: 3
Study 7265042 — intervention group
Group type: COMPARATOR
Intervention: Control group with simple film taken during nephrographic time (arterial time + 10 seconds)
Number of subjects: 3
Study 30578750 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezoelectric surgery
Number of subjects: 21
Study 30578750 — intervention group
Group type: COMPARATOR
Intervention: Conventional rotatory technique
Number of subjects: 21
Study 28422864 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (100, 200, 1000 ng/mL)
Number of subjects: 0
Study 28422864 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (200 ng/mL)
Number of subjects: 0
Study 28422864 — intervention group
Group type: COMPARATOR
Intervention: Control (vehicle)
Number of subjects: 0
Study 25482548 — intervention group
Group type: EXPERIMENTAL
Intervention: LISTERINE Antiseptic (LA)
Number of subjects: 0
Study 25482548 — intervention group
Group type: COMPARATOR
Intervention: Crest Pro‐Health Rinse (CPH)
Number of subjects: 0
Study 24797262 — intervention group
Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (nucleoside analogue)
Number of subjects: 18
Study 24797262 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment interruption
Number of subjects: 18
Study 24797262 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment interruption in patients with low on-treatment levels of serum IFN‐γ
Number of subjects: 18
Study 22633079 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric diet
Number of subjects: 55
Study 22633079 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercaloric diet
Number of subjects: 55
Study 22633079 — intervention group
Group type: COMPARATOR
Intervention: Eucaloric diet
Number of subjects: 55
Study 22633079 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy intake and balance
Number of subjects: 55
Study 20926321 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual compression during UGFS
Number of subjects: 8
Study 20926321 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical ligation of the SF junction
Number of subjects: 8
Study 20926321 — intervention group
Group type: COMPARATOR
Intervention: No compression during UGFS
Number of subjects: 8
Study 18347895 — intervention group
Group type: EXPERIMENTAL
Intervention: TPB-based behavior change intervention (print materials alone or combined with a step pedometer)
Number of subjects: 377
Study 18347895 — intervention group
Group type: COMPARATOR
Intervention: Standard public health recommendation for PA (SR group)
Number of subjects: 377
Study 15734776 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 248
Study 15734776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study 12190751 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral flumazenil
Number of subjects: 18
Study 12190751 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 18
Study 10597552 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-N2O
Number of subjects: 40
Study 10597552 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane-N2O
Number of subjects: 40
Study 8813983 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional treatment with additional biofeedback training (CT+BF)
Number of subjects: 192
Study 8813983 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (CT)
Number of subjects: 192
Study 1567626 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperkalemic cold cardioplegia and initial hyperkalemic reperfusion
Number of subjects: 160
Study 1567626 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncardioplegic blood reperfusate
Number of subjects: 160
Study 1567626 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized protocols with initial cardioplegic reperfusion
Number of subjects: 160
Study 1567626 — intervention group
Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 160
Study 2861567 — intervention group
Group type: EXPERIMENTAL
Intervention: OKT3 monoclonal antibody treatment for acute rejection, daily for a mean of 14 days, with concomitant lowering of other immunosuppressive drugs.
Number of subjects: 123
Study 2861567 — intervention group
Group type: COMPARATOR
Intervention: Conventional high-dose steroids treatment for acute rejection.
Number of subjects: 123
Study 2861567 — intervention group
Group type: EXPERIMENTAL
Intervention: OKT3 treatment group.
Number of subjects: 123
Study 2861567 — intervention group
Group type: COMPARATOR
Intervention: Conventional high-dose steroids treatment group.
Number of subjects: 123
Study 31183443 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine applicator
Number of subjects: 498
Study 31183443 — intervention group
Group type: COMPARATOR
Intervention: Conventional sterilization
Number of subjects: 498
Study 30116110 — intervention group
Group type: EXPERIMENTAL
Intervention: RG (Plyometric Jump Training with randomization)
Number of subjects: 19
Study 30116110 — intervention group
Group type: EXPERIMENTAL
Intervention: NRG (Plyometric Jump Training without randomization)
Number of subjects: 19
Study 30116110 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study 27942206 — intervention group
Group type: EXPERIMENTAL
Intervention: Carers’ education and ultrasound baths for denture cleaning
Number of subjects: 219
Study 27942206 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 219
Study 25252490 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostafit
Number of subjects: 100
Study 25252490 — intervention group
Group type: COMPARATOR
Intervention: Prazosin
Number of subjects: 100
Study 25252490 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostafit and Prazosin
Number of subjects: 100
Study 22842057 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of tranexamic acid (5 g in 100 ml saline solution)
Number of subjects: 89
Study 22842057 — intervention group
Group type: COMPARATOR
Intervention: Placebo (100 ml saline solution)
Number of subjects: 89
Study 19948872 — intervention group
Group type: EXPERIMENTAL
Intervention: GFR <60 ml/min/1.73 m(2)
Number of subjects: 3851
Study 19948872 — intervention group
Group type: EXPERIMENTAL
Intervention: GFR <60 ml/min/1.73 m(2) in women without pre-existing CVD
Number of subjects: 3851
Study 19948872 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with pre-existing CVD
Number of subjects: 3851
Study 17627004 — intervention group
Group type: EXPERIMENTAL
Intervention: High fruit-vegetable diet
Number of subjects: 122
Study 17627004 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 122
Study 17627004 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination low-fat/high fruit-vegetable diet
Number of subjects: 122
Study 17627004 — intervention group
Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 122
Study 16096517 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (50-100 mg/day)
Number of subjects: 240
Study 16096517 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study 12474549 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone-replacement therapy (HRT)
Number of subjects: 0
Study 12474549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10454016 — intervention group
Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 21
Study 10454016 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 21
Study 10454016 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 21
Study 8645892 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate hydration plus ANP infusion (ANP group)
Number of subjects: 40
Study 8645892 — intervention group
Group type: COMPARATOR
Intervention: Maximal hydration (MH) regimen (control group)
Number of subjects: 40
Study 8645892 — intervention group
Group type: EXPERIMENTAL
Intervention: ANP group
Number of subjects: 40
Study 1698429 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost (IL)
Number of subjects: 12
Study 1698429 — intervention group
Group type: COMPARATOR
Intervention: Prostacyclin (PGI2)
Number of subjects: 12
Study 7391323 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenosem salicylate
Number of subjects: 10
Study 7391323 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 10
Study 31710601 — intervention group
Group type: EXPERIMENTAL
Intervention: Full oxygen system
Number of subjects: 24859
Study 31710601 — intervention group
Group type: COMPARATOR
Intervention: Pulse oximetry
Number of subjects: 24859
Study 28152170 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity counseling intervention
Number of subjects: 398
Study 28152170 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 398
Study 26406467 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained lung inflations (SLI) - 1-3 SLI (30 cmH2O for 15 s) followed by respiratory standard care.
Number of subjects: 40
Study 26406467 — intervention group
Group type: COMPARATOR
Intervention: Control group - respiratory standard care only.
Number of subjects: 40
Study 26406467 — intervention group
Group type: COMPARATOR
Intervention: Comparison between SLI and Control groups.
Number of subjects: 40
Study 24331773 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based cognitive behavioural weight management programme
Number of subjects: 49
Study 20835746 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted lifestyle intervention
Number of subjects: 198
Study 19965029 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 0
Study 17258387 — intervention group
Group type: COMPARATOR
Intervention: Catheterized group (C) - polyurethane catheter (5F) passed through the ureter after lithotripsy, removed after 24h
Number of subjects: 140
Study 17258387 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncatheterized group (NC) - no catheterization
Number of subjects: 140
Study 15090934 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with Parkinson disease and migraine
Number of subjects: 28
Study 15090934 — intervention group
Group type: COMPARATOR
Intervention: Patients without migraine
Number of subjects: 28
Study 11576102 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral midazolam premedication
Number of subjects: 50
Study 11576102 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 9778067 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg body weight)
Number of subjects: 12
Study 9778067 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7871107 — intervention group
Group type: EXPERIMENTAL
Intervention: High cynical distrust and high anger-control
Number of subjects: 119
Study 7871107 — intervention group
Group type: COMPARATOR
Intervention: Established biological risk factors (serum low-density lipoprotein cholesterol concentration, smoking, old age)
Number of subjects: 119
Study 3175455 — intervention group
Group type: EXPERIMENTAL
Intervention: Single puff of 100 microliters volume
Number of subjects: 13
Study 3175455 — intervention group
Group type: EXPERIMENTAL
Intervention: Two puffs of 50 microliters
Number of subjects: 13
Study 3175455 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased spray cone angle from 60 degrees to 35 degrees
Number of subjects: 13
Study 30094707 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant therapy
Number of subjects: 0
Study 30094707 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical R0 resection
Number of subjects: 0
Study 30094707 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant radiochemotherapy and chemotherapy
Number of subjects: 0
Study 30094707 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative chemotherapy
Number of subjects: 0
Study 27038440 — intervention group
Group type: EXPERIMENTAL
Intervention: betamethasone valerate cream
Number of subjects: 15
Study 27038440 — intervention group
Group type: EXPERIMENTAL
Intervention: roflumilast 0.5% cream
Number of subjects: 15
Study 27038440 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK‐084 0.5% cream
Number of subjects: 15
Study 27038440 — intervention group
Group type: EXPERIMENTAL
Intervention: TAK‐084 5% cream
Number of subjects: 15
Study 27038440 — intervention group
Group type: EXPERIMENTAL
Intervention: calcipotriol 0.005% cream
Number of subjects: 15
Study 27038440 — intervention group
Group type: COMPARATOR
Intervention: vehicle cream
Number of subjects: 15
Study 26177521 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Health History (FHH) assessment
Number of subjects: 116
Study 26177521 — intervention group
Group type: COMPARATOR
Intervention: Control information
Number of subjects: 116
Study 23601333 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (VSL#3, 900 billion/day)
Number of subjects: 94
Study 23601333 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics (norfloxacin 400 mg BD)
Number of subjects: 94
Study 23601333 — intervention group
Group type: COMPARATOR
Intervention: Propranolol alone
Number of subjects: 94
Study 23601333 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (VSL#3)
Number of subjects: 94
Study 23601333 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics (norfloxacin)
Number of subjects: 94
Study 20152700 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy (CRT)
Number of subjects: 40
Study 20152700 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of dyssynchrony with epsilon-pl < -7.8%
Number of subjects: 40
Study 19189671 — intervention group
Group type: EXPERIMENTAL
Intervention: XP‐Bond applied on collagen-depleted dentin (group 1)
Number of subjects: 2
Study 19189671 — intervention group
Group type: COMPARATOR
Intervention: XP‐Bond applied in accordance with manufacturers' instructions (group 2)
Number of subjects: 2
Study 19189671 — intervention group
Group type: EXPERIMENTAL
Intervention: XP‐Bond applied on collagen-depleted dentin (group 1) after 6 months
Number of subjects: 2
Study 19189671 — intervention group
Group type: COMPARATOR
Intervention: XP‐Bond applied in accordance with manufacturers' instructions (group 2) after 6 months
Number of subjects: 2
Study 19189671 — intervention group
Group type: EXPERIMENTAL
Intervention: Interfacial nanoleakage expression along XP‐Bond adhesive interfaces
Number of subjects: 2
Study 15708298 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐cycloserine (n = 6)
Number of subjects: 12
Study 15708298 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 6)
Number of subjects: 12
Study 12902095 — intervention group
Group type: EXPERIMENTAL
Intervention: Embol-X intraaortic filter
Number of subjects: 1289
Study 12902095 — intervention group
Group type: COMPARATOR
Intervention: Control (nonfiltered)
Number of subjects: 1289
Study 10566920 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.125%
Number of subjects: 50
Study 10566920 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.2%
Number of subjects: 50
Study 8609337 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine-atropine stress echocardiography
Number of subjects: 360
Study 8609337 — intervention group
Group type: COMPARATOR
Intervention: Dipyridamole-atropine stress echocardiography
Number of subjects: 360
Study 2019161 — intervention group
Group type: EXPERIMENTAL
Intervention: Metaproterenol (5 percent solution, 0.3 ml) plus atropine sulfate (2.5 mg)
Number of subjects: 40
Study 2019161 — intervention group
Group type: COMPARATOR
Intervention: Metaproterenol (5 percent solution, 0.3 ml) alone
Number of subjects: 40
Study 400931 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin
Number of subjects: 596
Study 400931 — intervention group
Group type: COMPARATOR
Intervention: Cephalothin
Number of subjects: 596
Study 31092617 — intervention group
Group type: EXPERIMENTAL
Intervention: Biosimilar ABP 215
Number of subjects: 0
Study 31092617 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 0
Study 28758951 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation (Fe condition) - 12 mg of iron twice daily (24 mg/day)
Number of subjects: 14
Study 28758951 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Control condition; CON) - no iron supplementation
Number of subjects: 14
Study 26040352 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss program (22 weeks, 3 times/week training, hypocaloric diet 25-30% less energy intake)
Number of subjects: 180
Study 23880084 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tidal volume ventilation (6 mL/kg)
Number of subjects: 16
Study 23880084 — intervention group
Group type: COMPARATOR
Intervention: High tidal volume ventilation (12 mL/kg)
Number of subjects: 16
Study 21269646 — intervention group
Group type: EXPERIMENTAL
Intervention: landiolol hydrochloride
Number of subjects: 140
Study 21269646 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 140
Study 18496750 — intervention group
Group type: EXPERIMENTAL
Intervention: Erlotinib (150 mg orally daily)
Number of subjects: 69
Study 17711594 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral lobar placement of endobronchial valves plus optimal medical management
Number of subjects: 270
Study 17711594 — intervention group
Group type: COMPARATOR
Intervention: Optimal medical management alone
Number of subjects: 270
Study 15482074 — intervention group
Group type: EXPERIMENTAL
Intervention: Population of linear experts model (POLE)
Number of subjects: 3
Study 15482074 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 3
Study 11468032 — intervention group
Group type: EXPERIMENTAL
Intervention: Etifoxine 50 mg
Number of subjects: 48
Study 11468032 — intervention group
Group type: EXPERIMENTAL
Intervention: Etifoxine 100 mg
Number of subjects: 48
Study 11468032 — intervention group
Group type: COMPARATOR
Intervention: Lorazepam 2 mg
Number of subjects: 48
Study 9763356 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamins (specific type and dosage not mentioned)
Number of subjects: 0
Study 9763356 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7845693 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental lenses (dyed to provide appropriate chromaticity)
Number of subjects: 68
Study 7845693 — intervention group
Group type: COMPARATOR
Intervention: Control lenses (similar colour but with chromaticity outside the range of improvement)
Number of subjects: 68
Study 3398242 — intervention group
Group type: EXPERIMENTAL
Intervention: DDD pacing mode
Number of subjects: 18
Study 3398242 — intervention group
Group type: COMPARATOR
Intervention: VVI pacing mode
Number of subjects: 18
Study 30346346 — intervention group
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA injection
Number of subjects: 120
Study 28376756 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guided needling and lavage (barbotage) with subacromial steroid injection
Number of subjects: 210
Study 28376756 — intervention group
Group type: COMPARATOR
Intervention: Sham barbotage with subacromial steroid injection
Number of subjects: 210
Study 28376756 — intervention group
Group type: COMPARATOR
Intervention: Sham barbotage without subacromial steroid injection (placebo group)
Number of subjects: 210
Study 26118515 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote after‐effects of resistive static contraction of the pelvic depressors (RSCPD)
Number of subjects: 10
Study 26118515 — intervention group
Group type: COMPARATOR
Intervention: After‐effects of static contraction of upper extremity muscles (SCUE)
Number of subjects: 10
Study 23299003 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based internet obesity prevention program with coping skills training
Number of subjects: 384
Study 23299003 — intervention group
Group type: COMPARATOR
Intervention: School-based internet obesity prevention program without coping skills training
Number of subjects: 384
Study 21450115 — intervention group
Group type: EXPERIMENTAL
Intervention: dairy-Se (150 μg/d)
Number of subjects: 23
Study 21450115 — intervention group
Group type: EXPERIMENTAL
Intervention: yeast-Se (150 μg/d)
Number of subjects: 23
Study 19083557 — intervention group
Group type: COMPARATOR
Intervention: Body contouring surgery in the ideal weight group
Number of subjects: 129
Study 19083557 — intervention group
Group type: EXPERIMENTAL
Intervention: Body contouring surgery in the severely morbidly obese group
Number of subjects: 129
Study 19083557 — intervention group
Group type: EXPERIMENTAL
Intervention: Body contouring surgery in the obese group
Number of subjects: 129
Study 19083557 — intervention group
Group type: EXPERIMENTAL
Intervention: Body contouring surgery in the morbidly obese group
Number of subjects: 129
Study 17926615 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal acupuncture at Zhongwan (CV 12), Guanyuan (CV 4) and others
Number of subjects: 62
Study 17926615 — intervention group
Group type: COMPARATOR
Intervention: Traditional acupuncture at Fengchi (GB 20) and cervical Jiaji (EX-B 2)
Number of subjects: 62
Study 15483410 — intervention group
Group type: EXPERIMENTAL
Intervention: Aselizumab 0.5 mg/kg
Number of subjects: 84
Study 15483410 — intervention group
Group type: EXPERIMENTAL
Intervention: Aselizumab 1 mg/kg
Number of subjects: 84
Study 15483410 — intervention group
Group type: EXPERIMENTAL
Intervention: Aselizumab 2 mg/kg
Number of subjects: 84
Study 15483410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 15483410 — intervention group
Group type: EXPERIMENTAL
Intervention: Aselizumab (all dosages)
Number of subjects: 84
Study 11529339 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.3 mg/kg
Number of subjects: 60
Study 11529339 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg/kg
Number of subjects: 60
Study 11529339 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 0.9 mg/kg
Number of subjects: 60
Study 9773794 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenolphthalein alone
Number of subjects: 6
Study 9773794 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin plus Phenolphthalein
Number of subjects: 6
Study 9773794 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorbitol plus Resin
Number of subjects: 6
Study 9773794 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 9773794 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin regimens (various)
Number of subjects: 6
Study 7835118 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dosage growth hormone (GH) co-administered with gonadotropin (Gn)
Number of subjects: 0